Literature DB >> 15613591

Hospital admissions for bronchiolitis in preterm infants in the absence of respiratory syncytial virus prophylaxis.

P Bala, C A Ryan, B P Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15613591      PMCID： PMC1721827          DOI： 10.1136/adc.2003.036012

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN： 1359-2998            Impact factor:   5.747


× No keyword cloud information.
  3 in total

1.  RSV and bronchiolitis.

Authors:  H L A Van Rostenberghe; S T Kew; M J M Hanifah
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-03       Impact factor: 5.747

2.  Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV).

Authors:  Joseph M Geskey; Neal J Thomas; Gretchen L Brummel
Journal:  Biologics       Date:  2007-03

Review 3.  Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease.

Authors:  Josep Figueras-Aloy; Paolo Manzoni; Bosco Paes; Eric A F Simões; Louis Bont; Paul A Checchia; Brigitte Fauroux; Xavier Carbonell-Estrany
Journal:  Infect Dis Ther       Date:  2016-09-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.